Cargando…
Lymph Node-Targeting Nanovaccine through Antigen-CpG Self-Assembly Potentiates Cytotoxic T Cell Activation
Therapeutic vaccines that arouse the cytotoxic T cell immune response to reject infected cells have been investigated extensively for treating disease. Due to the large amounts of resident antigen-presenting cells (APCs) and T cells in lymph nodes, great efforts have been made to explore the strateg...
Autores principales: | Xi, Xiaobo, Zhang, Lijun, Lu, Guihong, Gao, Xiaoyong, Wei, Wei, Ma, Guanghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029500/ https://www.ncbi.nlm.nih.gov/pubmed/30018987 http://dx.doi.org/10.1155/2018/3714960 |
Ejemplares similares
-
CpG-Based Nanovaccines for Cancer Immunotherapy
por: Chen, Wenqiang, et al.
Publicado: (2021) -
Enhancement of Immune Response of Bioconjugate Nanovaccine by Loading of CpG through Click Chemistry
por: Mo, Mengting, et al.
Publicado: (2023) -
Targeted Delivery of Immunostimulatory CpG Oligodeoxynucleotides to Antigen-Presenting Cells in Draining Lymph Nodes by Stearic Acid Modification and Nanostructurization
por: Nagaoka, Makoto, et al.
Publicado: (2022) -
Fibronectin EDA and CpG synergize to enhance antigen-specific Th1 and cytotoxic responses
por: Julier, Ziad, et al.
Publicado: (2016) -
Preservation of methylated CpG dinucleotides in human CpG islands
por: Panchin, Alexander Y., et al.
Publicado: (2016)